Oct 1, 2013 by Brandy BetzA Gaming King Rumored for IPOThe maker of Candy Crush Saga might've filed for a secretive IPO. Would the company have an easier ride than Zynga?
Sep 26, 2013 by Brandy Betz3 Easy Ways to Add Portfolio Stability Want to add portfolio stability in a hurry? Consider these three ETF tactics.
Sep 24, 2013 by Brandy Betz1 Easy Way to Become a Utility InvestorConfused by the wide world of utility stocks? This sector ETF can get you started.
Sep 24, 2013 by Brandy Betz4 Picks for Large-Cap GrowthSmall-caps don't get to have all the fun. Check out four large-cap ETFs with growth ahead.
Sep 17, 2013 by Brandy BetzWill This Dividend Stock Have a Happier Holiday? Target's 2012 holiday season showed some weakness. Will this year's shopping rush prove more optimistic?
Sep 13, 2013 by Brandy Betz4 Royal High-Yield Energy StocksRoyalty trusts attract investors with high dividend yields. Here's four leading energy trusts for your portfolio.
Sep 12, 2013 by Brandy Betz3 Launchpads for Dividend InvestorsWant to sample the world of dividend investing? Here are three ETFs to get you started.
Sep 11, 2013 by Brandy BetzAre the Dogs of the Dow Still in the Race? Will the 10 highest-yielding dividend stocks outperform the Dow this year?
Sep 6, 2013 by Brandy Betz3 Lower-Risk Ways to Invest in Health CareA sector ETF offers a taste of an industry with lower risk. What are the top health care ETFs?
Aug 27, 2013 by Brandy BetzDid a Strong New Drug Make This Biotech Overvalued?Santarus launched an anticipated product during the first quarter. Did investor optimism drive Santarus to become overvalued?
Aug 27, 2013 by Brandy Betz3 PDUFA Dates That Will Kick Off 2014 AstraZeneca, Bristol-Myers Squibb, and BioMarin all have drugs heading for a PDUFA date in Q1. Which company is most dependent on a victory?
Aug 27, 2013 by Brandy BetzPositive News for This Troubled Pharma PlayerEli Lilly's facing two big patent cliffs with an unsteady pipeline. But the resurrection of a late-stage cancer drug could help ease the bumpy road ahead.